新股消息 | 焦点国际递表港交所 主营吸收性卫生产品制造及销售

Core Viewpoint - Focus International Limited has submitted a listing application to the Hong Kong Stock Exchange, with Jianquan Financing Limited as its sole sponsor [1] Business Overview - Focus International primarily engages in the manufacturing and sales of absorbent hygiene products, which are categorized into three types: baby care products, feminine care products, and adult incontinence products. The company also sells materials for hygiene products [4] - The company employs a multi-brand strategy to offer a wide range of absorbent hygiene products mainly in China, with brands including "Cotton Hour Light," "Focus Baby," and "Baimule" for baby care, and "Weiyue" and "Blue Cotton Flower" for feminine care [4] Operational Segments - The business operates in three segments: 1. OEM Business: Provides manufacturing services for both Chinese and international brand owners, with revenue increasing from RMB 64 million in FY2022 to RMB 108 million in FY2024, accounting for 24.1% of total revenue in FY2024 [5] 2. Brand Products Business: Focuses on the research, production, and sales of proprietary absorbent hygiene products in China, with revenue rising from RMB 13.5 million in FY2022 to RMB 160 million in FY2024, representing 35.8% of total revenue in FY2024 [5] 3. Hygiene Product Materials Business: Involves sourcing raw materials and processing them into standardized materials like SAP, hot melt adhesive, and non-woven fabric, with revenue increasing from RMB 104 million in FY2022 to RMB 179 million in FY2024, making up 40.1% of total revenue in FY2024 [5] Client and Production Capacity - The company's top five clients accounted for approximately 44.4%, 36.3%, and 39.9% of total revenue during the reporting periods, with the largest client contributing about 16.2%, 13.7%, and 13.1% respectively [6] - Focus International operates eight production lines in Quanzhou, Fujian Province, with a significant portion of the production process being automated [6] Financial Performance - The company reported total revenues of approximately RMB 181 million, RMB 372 million, and RMB 447 million for FY2022, FY2023, and FY2024 respectively, with net profits of RMB 12.3 million, RMB 39.5 million, and RMB 65.6 million during the same periods [8][9]